This finding was consistent with prior studies demonstrating that loss of NF1 may be a predictive biomarker for ERK-dependent regulation of cell proliferation.34,39 Combined inhibition of mTOR and MEK pathways led to a synergistic antiproliferative effect in many GBM lines, regardless of NF1 expression. The gene discussed is NF1; the disease is glioblastoma.